Literature DB >> 31191868

Dual inhibitors of LSD1 and spermine oxidase.

Steven Holshouser1, Matthew Dunworth2, Tracy Murray-Stewart2, Yuri K Peterson1, Pieter Burger1, Joy Kirkpatrick1, Huan-Huan Chen1, Robert A Casero2, Patrick M Woster1.   

Abstract

We have previously described the synthesis and evaluation of 3,5-diamino-1,2,4-triazole analogues as inhibitors of the flavin-dependent histone demethylase LSD1. These compounds are potent inhibitors of LSD1 without activity against monoamine oxidases A and B, and promote the elevation of H3K4me2 levels in tumor cells in vitro. We now report that the cytotoxicity of these analogues in pancreatic tumor cells correlates with the overexpression of LSD1 in each tumor type. In addition, we show that a subset of these 3,5-diamino-1,2,4-triazole analogues inhibit a related flavin-dependent oxidase, the polyamine catabolic enzyme spermine oxidase (SMOX) in vitro.

Entities:  

Year:  2019        PMID: 31191868      PMCID: PMC6533887          DOI: 10.1039/c8md00610e

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  28 in total

1.  Properties of purified recombinant human polyamine oxidase, PAOh1/SMO.

Authors:  Yanlin Wang; Tracy Murray-Stewart; Wendy Devereux; Amy Hacker; Benjamin Frydman; Patrick M Woster; Robert A Casero
Journal:  Biochem Biophys Res Commun       Date:  2003-05-16       Impact factor: 3.575

2.  A mechanism-based inactivator for histone demethylase LSD1.

Authors:  Jeffrey C Culhane; Lawrence M Szewczuk; Xin Liu; Guoping Da; Ronen Marmorstein; Philip A Cole
Journal:  J Am Chem Soc       Date:  2006-04-12       Impact factor: 15.419

3.  Structural basis of LSD1-CoREST selectivity in histone H3 recognition.

Authors:  Federico Forneris; Claudia Binda; Antonio Adamo; Elena Battaglioli; Andrea Mattevi
Journal:  J Biol Chem       Date:  2007-05-30       Impact factor: 5.157

4.  Inhibition of acetylpolyamine and spermine oxidases by the polyamine analogue chlorhexidine.

Authors:  Manuela Cervelli; Fabio Polticelli; Laura Fiorucci; Emanuela Angelucci; Rodolfo Federico; Paolo Mariottini
Journal:  J Enzyme Inhib Med Chem       Date:  2012-02-03       Impact factor: 5.051

5.  (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.

Authors:  Shiv K Sharma; Yu Wu; Nora Steinbergs; Michael L Crowley; Allison S Hanson; Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

Review 6.  The polyamine oxidase inactivator MDL 72527.

Authors:  Nikolaus Seiler; Benoit Duranton; Francis Raul
Journal:  Prog Drug Res       Date:  2002

7.  Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis.

Authors:  C A Faaland; T J Thomas; S Balabhadrapathruni; T Langer; S Mian; A Shirahata; M A Gallo; T Thomas
Journal:  Biochem Cell Biol       Date:  2000       Impact factor: 3.626

8.  Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.

Authors:  Yi Huang; Tracy Murray Stewart; Yu Wu; Stephen B Baylin; Laurence J Marton; Brandy Perkins; Richard J Jones; Patrick M Woster; Robert A Casero
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

9.  Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes.

Authors:  Yi Huang; Eriko Greene; Tracy Murray Stewart; Andrew C Goodwin; Stephen B Baylin; Patrick M Woster; Robert A Casero
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

10.  Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells.

Authors:  Wendy Devereux; Yanlin Wang; Tracy Murray Stewart; Amy Hacker; Renee Smith; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton; Tracey D Ward; Patrick M Woster; Robert A Casero
Journal:  Cancer Chemother Pharmacol       Date:  2003-06-25       Impact factor: 3.333

View more
  6 in total

Review 1.  Histone lysine specific demethylase 1 inhibitors.

Authors:  Samir Mehndiratta; Jing-Ping Liou
Journal:  RSC Med Chem       Date:  2020-07-31

2.  Epigenetic Reexpression of Hemoglobin F Using Reversible LSD1 Inhibitors: Potential Therapies for Sickle Cell Disease.

Authors:  Steven Holshouser; Rebecca Cafiero; Mayra Robinson; Joy Kirkpatrick; Robert A Casero; Hyacinth I Hyacinth; Patrick M Woster
Journal:  ACS Omega       Date:  2020-06-09

3.  Identification of a Novel Substrate-Derived Spermine Oxidase Inhibitor.

Authors:  T T Dunston; M A Khomutov; S B Gabelli; T M Stewart; J R Foley; S N Kochetkov; A R Khomutov; R A Casero
Journal:  Acta Naturae       Date:  2020 Jul-Sep       Impact factor: 1.845

4.  Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia.

Authors:  Yang Li; Ying Sun; Yang Zhou; Xinyang Li; Huan Zhang; Guojun Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  Structure of human spermine oxidase in complex with a highly selective allosteric inhibitor.

Authors:  Elsie Diaz; Suraj Adhikary; Armand W J W Tepper; Daniel Riley; Rodrigo Ortiz-Meoz; Daniel Krosky; Christophe Buyck; Carolina Martinez Lamenca; Josep Llaveria; Lichao Fang; Jay H Kalin; Vincent N A Klaren; Shorouk Fahmy; Paul L Shaffer; Robert Kirkpatrick; Rodrigo J Carbajo; Maren Thomsen; Antonietta Impagliazzo
Journal:  Commun Biol       Date:  2022-08-05

6.  Identification and Characterization of Novel Small-Molecule SMOX Inhibitors.

Authors:  Amelia B Furbish; Ahmed S Alford; Pieter Burger; Yuri K Peterson; Tracy Murray-Stewart; Robert A Casero; Patrick M Woster
Journal:  Med Sci (Basel)       Date:  2022-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.